Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Occupational Health and Emergency Rescue / Zhiye Weisheng yu Yingji Jiuyuan ; 40(3):282-286, 2022.
Article in Chinese | GIM | ID: covidwho-2269275

ABSTRACT

Objective: To understand the anxiety and insomnia of nurses in 2020 and its influencing factors, so as to provide orientation for formulating relevant policies. Methods: A total of 738 nurses in a designated hospital for treatment of COVID-19 patients in Quanzhou were investigated by convenient sampling. The basic demographic information, cognition of COVID-19, anxiety and insomnia of these subjects were surveyed with self-made questionnaire, self rating anxiety scale (SAS) and insomnia severity index(ISI). The influencing factors of anxiety and insomnia were analyzed by multiple linear regression. Results: The incidence of anxiety and insomnia were 8.5% and 35.8%, respectively. The results of multiple linear regression analysis showed that regular physical exercise was the influencing factor to reduce nurses' anxiety(beta =-4.226, P = 0.002) and insomnia (beta = - 1.706, P = 0.003). Nurses who had a personal history of disease (beta = 3.320, P = 0.023), considered resignation due to the COVID -19 (beta = 5.012, P = 0.031), thought that they might infect their family members and/or friends with COVID-19 virus (beta = 4.631, P < 0.001) and were treated differently by others (beta = 3.829, P = 0.003) had more anxiety;nursing staff who had a personal history of disease (beta = 1.277, P = 0.036), considered resignation due to the COVID-19 (beta =1.946, P = 0.045), worried about infecting other people with novel coronavirus (beta = 1.063, P = 0.006), thought that they might infect their family and friends with COVID-19 virus (beta =1.156, P = 0.003) and were treated differently by others (beta =1.507, P = 0.004) also had more serious insomnia. There was a positive correlation between anxiety and insomnia[beta and its 95% CI value was 0.280(0.258, 0.302, P < 0.001)]. Conclusions: In 2020 nurses in Quanzhou had anxiety and insomnia, which were affected by many factors. Employers should pay attention to the mental health of high-risk personnel and carry out psychological intervention when necessary.

2.
Int J Infect Dis ; 130: 60-70, 2023 May.
Article in English | MEDLINE | ID: covidwho-2265428

ABSTRACT

OBJECTIVES: Asymptomatic infections and mild diseases were more common during the Omicron outbreak in Shanghai, China in 2022. This study aimed to assess the characteristics and viral RNA decay between patients with asymptomatic and mild infections. METHODS: A total of 55,111 patients infected with SARS-CoV-2 who were quarantined in the National Exhibition & Convention Center (Shanghai) Fangcang shelter hospital within 3 days after diagnosis from April 9 to May 23, 2022 were enrolled. The kinetics of cycle threshold (Ct) values of reverse transcription-polymerase chain reaction were assessed. The influencing factors for disease progression and the risk factors for the viral RNA shedding time (VST) were investigated. RESULTS: On admission, 79.6% (43,852/55,111) of the cases were diagnosed with asymptomatic infections, and 20.4% were mild diseases. However, 78.0% of initially asymptomatic subjects developed mild diseases at the follow-up. The final proportion of asymptomatic infections was 17.5%. The median time of symptom onset, the duration of symptoms, and the VST were 2 days, 5 days, and 7 days, respectively. Female, age 19-40 years, underlying comorbidities with hypertension and diabetes, and vaccination were associated with higher risks of progressing to mildly symptomatic infections. In addition, mildly symptomatic infections were found to be associated with prolonged VST compared with asymptomatic infections. However, the kinetics of viral RNA decay and dynamics of Ct values were similar among asymptomatic subjects, patients with asymptomatic-to-mild infection, and patients with mild infection. CONCLUSION: A large proportion of initially diagnosed asymptomatic Omicron infections is in the presymptomatic stage. The Omicron infection has a much shorter incubation period and VST than previous variants. The infectivity of asymptomatic infections and mildly symptomatic infections with Omicron is similar.


Subject(s)
COVID-19 , SARS-CoV-2 , Humans , Female , Young Adult , Adult , SARS-CoV-2/genetics , COVID-19/diagnosis , COVID-19/epidemiology , RNA, Viral/genetics , Asymptomatic Infections/epidemiology , Retrospective Studies , Hospitals, Special , China/epidemiology , Mobile Health Units
3.
Cell Discov ; 9(1): 3, 2023 Jan 07.
Article in English | MEDLINE | ID: covidwho-2185789

ABSTRACT

SARS-CoV-2 Omicron subvariants have demonstrated extensive evasion from monoclonal antibodies (mAbs) developed for clinical use, which raises an urgent need to develop new broad-spectrum mAbs. Here, we report the isolation and analysis of two anti-RBD neutralizing antibodies BA7208 and BA7125 from mice engineered to produce human antibodies. While BA7125 showed broadly neutralizing activity against all variants except the Omicron sublineages, BA7208 was potently neutralizing against all tested SARS-CoV-2 variants (including Omicron BA.1-BA.5) except Mu. By combining BA7208 and BA7125 through the knobs-into-holes technology, we generated a biparatopic antibody BA7208/7125 that was able to neutralize all tested circulating SARS-CoV-2 variants. Cryo-electron microscopy structure of these broad-spectrum antibodies in complex with trimeric Delta and Omicron spike indicated that the contact residues are highly conserved and had minimal interactions with mutational residues in RBD of current variants. In addition, we showed that administration of BA7208/7125 via the intraperitoneal, intranasal, or aerosol inhalation route showed potent therapeutic efficacy against Omicron BA.1 and BA.2 in hACE2-transgenic and wild-type mice and, separately, effective prophylaxis. BA7208/7125 thus has the potential to be an effective candidate as an intervention against COVID-19.

4.
Nurs Open ; 8(6): 3527-3537, 2021 11.
Article in English | MEDLINE | ID: covidwho-1220262

ABSTRACT

AIM: To investigate the influencing factors in professional identity of undergraduate nursing students after the outbreak of COVID-19. DESIGN: Cross-sectional study. METHODS: The study covered 2,999 nursing students in six undergraduate nursing schools. Several self-report questionnaires were used to collect the general information, psychological stress, coping styles and professional identity of the undergraduate nursing students. RESULTS: The overall average score of the professional identity of nursing students (3.67 ± 0.51) has increased significantly after the outbreak of COVID-19. The professional identity of the undergraduate nursing students was negatively correlated with psychological stress (r = -0.23, p < .001), expectation (r = -0.12, p < .001) and avoidance (r = -0.16, p < .001), but was positively correlated with solving problems (r = 0.18, p < .001) and seeking support (r = 0.12, p < .001). Academic performance, positions, grades, reasons for choosing a nursing profession, parents or relatives engaged in nursing work and the risk degree of residence were the factors influencing the professional identity score of undergraduate nursing students' (p < .001).


Subject(s)
COVID-19 , Education, Nursing, Baccalaureate , Students, Nursing , Adaptation, Psychological , Cross-Sectional Studies , Disease Outbreaks , Humans , SARS-CoV-2 , Stress, Psychological/epidemiology
5.
Commun Biol ; 4(1): 500, 2021 04 23.
Article in English | MEDLINE | ID: covidwho-1213942

ABSTRACT

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing COVID-19 pandemic, which has resulted in more than two million deaths at 2021 February . There is currently no approved therapeutics for treating COVID-19. The SARS-CoV-2 Spike protein is considered a key therapeutic target by many researchers. Here we describe the identification of several monoclonal antibodies that target SARS-CoV-2 Spike protein. One human antibody, CA521FALA, demonstrated neutralization potential by immunizing human antibody transgenic mice. CA521FALA showed potent SARS-CoV-2-specific neutralization activity against SARS-CoV-2 pseudovirus and authentic SARS-CoV-2 infection in vitro. CA521FALA also demonstrated having a long half-life of 9.5 days in mice and 9.3 days in rhesus monkeys. CA521FALA inhibited SARS-CoV-2 infection in SARS-CoV-2 susceptible mice at a therapeutic setting with virus titer of the lung reduced by 4.5 logs. Structural analysis by cryo-EM revealed that CA521FALA recognizes an epitope overlapping with angiotensin converting enzyme 2 (ACE2)-binding sites in SARS-CoV-2 RBD in the Spike protein. CA521FALA blocks the interaction by binding all three RBDs of one SARS-CoV-2 spike trimer simultaneously. These results demonstrate the importance for antibody-based therapeutic interventions against COVID-19 and identifies CA521FALA a promising antibody that reacts with SARS-CoV-2 Spike protein to strongly neutralize its activity.


Subject(s)
Antibodies, Monoclonal/pharmacology , Antibodies, Neutralizing/pharmacology , COVID-19/prevention & control , SARS-CoV-2/immunology , Spike Glycoprotein, Coronavirus/immunology , Angiotensin-Converting Enzyme 2/immunology , Angiotensin-Converting Enzyme 2/metabolism , Animals , Antibodies, Monoclonal/immunology , Antibodies, Neutralizing/immunology , COVID-19/epidemiology , COVID-19/virology , Humans , Male , Mice, Inbred C57BL , Mice, Transgenic , Pandemics , Protein Binding/drug effects , Receptors, Virus/immunology , Receptors, Virus/metabolism , SARS-CoV-2/metabolism , SARS-CoV-2/physiology , Spike Glycoprotein, Coronavirus/metabolism
6.
J Glob Health ; 10(2): 020510, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-1106357

ABSTRACT

BACKGROUND: As an emergent and fulminant infectious disease, Corona Virus Disease 2019 (COVID-19) has caused a worldwide pandemic. The early identification and timely treatment of severe patients are crucial to reducing the mortality of COVID-19. This study aimed to investigate the clinical characteristics and early predictors for severe COVID-19, and to establish a prediction model for the identification and triage of severe patients. METHODS: All confirmed patients with COVID-19 admitted by the Second Affiliated Hospital of Air Force Medical University were enrolled in this retrospective non-interventional study. The patients were divided into a mild group and a severe group, and the clinical data were compared between the two groups. Univariate and multivariate analysis were used to identify the independent early predictors for severe COVID-19, and the prediction model was constructed by multivariate logistic regression analysis. Receiver operating characteristic (ROC) curve was used to evaluate the predictive value of the prediction model and each early predictor. RESULTS: A total of 40 patients were enrolled in this study, of whom 19 were mild and 21 were severe. The proportions of patients with venerable age (≥60 years old), comorbidities, and hypertension in severe patients were higher than that of the mild (P < 0.05). The duration of fever and respiratory symptoms, and the interval from illness onset to viral clearance were longer in severe patients (P < 0.05). Most patients received at least one form of oxygen treatments, while severe patients required more mechanical ventilation (P < 0.05). Univariate and multivariate analysis showed that venerable age, hypertension, lymphopenia, hypoalbuminemia and elevated neutrophil lymphocyte ratio (NLR) were the independent high-risk factors for severe COVID-19. ROC curves demonstrated significant predictive value of age, lymphocyte count, albumin and NLR for severe COVID-19. The sensitivity and specificity of the newly constructed prediction model for predicting severe COVID-19 was 90.5% and 84.2%, respectively, and whose positive predictive value, negative predictive value and crude agreement were all over 85%. CONCLUSIONS: The severe COVID-19 risk model might help clinicians quickly identify severe patients at an early stage and timely take optimal therapeutic schedule for them.


Subject(s)
Clinical Laboratory Techniques/statistics & numerical data , Coronavirus Infections/diagnosis , Pneumonia, Viral/diagnosis , Risk Assessment/statistics & numerical data , Severity of Illness Index , Adult , Betacoronavirus , COVID-19 , COVID-19 Testing , Clinical Laboratory Techniques/methods , Coronavirus Infections/mortality , Female , Humans , Logistic Models , Male , Middle Aged , Pandemics , Pneumonia, Viral/mortality , Predictive Value of Tests , ROC Curve , Retrospective Studies , Risk Assessment/methods , SARS-CoV-2
7.
Curr Probl Cardiol ; 46(3): 100693, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-841119

ABSTRACT

Coronavirus disease 2019 (COVID-19) pandemic poses great challenge on public health globally. To clarify the impact of COVID-19 pandemic on in-hospital management and outcomes for ST-segment elevation myocardial infarction (STEMI) patients in the nonepicenter. We enrolled consecutive STEMI patients who visited Fuwai Hospital from January to March, 2020 (N = 73) and also established a historical control including all consecutive STEMI patients in the same period of 2019 (N = 95). The primary outcome was defined as a composite endpoint of all-cause death, heart failure, cardiac shock, and cardiac arrest during hospitalization. Emergency response for COVID-19 resulted in a significant 77.6% reduction in the number of primary percutaneous coronary intervention, and a trend toward higher rate of primary composite endpoint (15.1% vs 11.6%, P = 0.51). COVID-19 pandemic results in a significant reduction in emergent reperfusion therapy, and a trend toward higher in-hospital adverse events risk.


Subject(s)
COVID-19/epidemiology , Pandemics , Percutaneous Coronary Intervention/methods , Public Health , ST Elevation Myocardial Infarction/surgery , Beijing/epidemiology , Comorbidity , Coronary Angiography , Humans , SARS-CoV-2 , ST Elevation Myocardial Infarction/diagnosis , ST Elevation Myocardial Infarction/epidemiology , Time-to-Treatment
8.
Catheter Cardiovasc Interv ; 97(4): E475-E483, 2021 03.
Article in English | MEDLINE | ID: covidwho-684468

ABSTRACT

BACKGROUND: During coronavirus disease 2019 (COVID-19) epidemic, reducing the number of invasive procedure and choosing conservative medication strategy for patients with non-ST-segment elevation myocardial infarction (NSTEMI) is unavoidable. Whether this relatively conservative strategy will impact in-hospital outcome for NSTEMI patients remains unclear. METHODS AND RESULTS: The current study included all consecutive NSTEMI patients who visited the emergency department in Fuwai Hospital from February 1 to March 31, 2020 and all the NSTEMI patients in the same period of 2019 as a historical control. Very-high-risk patients were defined as clinical presentation of heart failure, cardiac shock, cardiac arrest, recurrent chest pain, and life-threatening arrhythmias. The primary outcome was in-hospital major adverse cardiac events (MACE), defined as a composite of all-cause death, recurrent myocardial infarction, or heart failure. A total of 115 NSTEMI patients were enrolled since the outbreak of COVID-19, and a total of 145 patients were included in the control group. There was a tendency toward higher MACE risk in 2020 compared with 2019 (18.3% vs. 11.7%, p = .14). Among very-high-risk patients, early percutaneous coronary intervention (PCI) strategy in 2019 was associated with reduced MACE risk compared with delayed PCI in 2020 (60.6% [20/33] in 2020 vs. 27.9% [12/43] in 2019, p = .01). CONCLUSIONS: COVID-19 pandemic results in a significant reduction in immediate/early PCI and a trend toward higher adverse event rate during hospitalization, particular in very-high-risk patients.


Subject(s)
COVID-19 , Cardiology Service, Hospital/trends , Cardiovascular Agents/therapeutic use , Coronary Artery Bypass/trends , Emergency Service, Hospital/trends , Non-ST Elevated Myocardial Infarction/therapy , Percutaneous Coronary Intervention/trends , Public Health/trends , Aged , Beijing , Cardiovascular Agents/adverse effects , Coronary Artery Bypass/adverse effects , Coronary Artery Bypass/mortality , Female , Heart Failure/etiology , Hospital Mortality/trends , Humans , Male , Middle Aged , Non-ST Elevated Myocardial Infarction/complications , Non-ST Elevated Myocardial Infarction/diagnosis , Non-ST Elevated Myocardial Infarction/mortality , Percutaneous Coronary Intervention/adverse effects , Percutaneous Coronary Intervention/mortality , Recurrence , Retrospective Studies , Risk Assessment , Risk Factors , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL